Although Bayer’s top-selling drug Xarelto lost market exclusivity in most geographies in 2024, the company still predicts it will see strong growth from the pharma business unit beginning in 2027.

Treating patients with aspirin after completion of standard adjuvant therapy for colorectal cancer failed to significantly ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

For decades, taking low-dose aspirin every day was widely recommended as an easy way to prevent heart attacks and strokes. But that advice has changed.

People without the risk of heart problems who consumed daily low-dose aspirin, it increased the chance of bleeding in the ...

Bayer was founded in the year 1863 in Barmen in North Rhine Westphalia in the west of what was then the Kingdom of Prussia, today modern Germany. "What started as a small but innovative dyestuffs ...

Bayer's venerable testosterone replacement product ... Grünenthal is paying up to €500 million ($501 million) for rights to Nebido (testosterone undecanoate), which is sold in around 80 ...

Bayer Cropscience Ltd. key Products/Revenue Segments include Insecticides, Pesticides, Herbicides, Weedicides & Fungicides, Other Operating Revenue, Scrap and Royalty Income for the year ending 31-Mar ...

2-Year U.S. Treasury Note Continuous Contract $102.797-0.008-0.01% 5-Year U.S. Treasury Note Continuous Contract $106.227-0.039-0.04% 10-Year U.S. Treasury Note Continuous Contract $108.547-0.063 ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Our research team assigns Gold ratings to strategies that they have the most conviction will outperform a relevant index, or most peers, over a market cycle on a risk-adjusted basis. It earns a ...